• 首頁
• 文章創作
• 個人相簿
• 訪客簿
• 作家簡介

	文章數：91

三希樓婚前派對適合嗎？》台中公益路餐廳推薦｜10間必吃美食實測評比

在地生活｜大台北　2026/04/22 00:34:11

身為一個熱愛美食、喜歡在城市裡挖掘驚喜的人，臺中公益路一直是我最常出沒的地方之一。這條路可說是「臺中人的美食戰場」，從精緻西餐到創意火鍋，從日式丼飯到義式早午餐，每走幾步，就會有完全不同的特色料理餐廳。 這次我特別花了一整個月，實際造訪了公益路上十間口碑不錯的餐廳。有的是網友熱推的打卡名店，也有隱藏在巷弄裡的小驚喜。我以環境氛圍、口味表現、價格CP值與再訪意願為基準，整理出這篇實測評比。希望能幫正在猶豫去哪裡吃飯的你，找到那一間「吃完會想再來」的餐廳。 評比標準與整理方向 這次我走訪的10家餐廳橫跨不同料理類型，從高質感牛排館到巷弄系早午餐，每一間都有自己獨特的風格。為了讓整體比較更客觀，我依照以下四大面向進行評比，並搭配實際用餐體驗來打分。 評分項目 滿分5分 評比重點 環境氛圍 ⭐⭐⭐⭐⭐ 用餐空間是否舒適、有設計感、適合聚會或約會 口味表現 ⭐⭐⭐⭐⭐ 餐點是否新鮮、調味平衡、有無記憶點 CP值 ⭐⭐⭐⭐⭐ 價位與份量是否合理，是否值得回訪 再訪意願 ⭐⭐⭐⭐⭐ 整體體驗是否令人想再來、服務是否加分 整體而言，我希望這份評比不只是「哪家好吃」，而是幫你在不同情境下（約會、家庭聚餐、朋友小聚、商業午餐）都能快速找到合適的選擇。畢竟，美食不只是味覺的滿足，更是一段段與朋友共享的生活記憶。 10間臺中公益路餐廳評比懶人包 公益路向來是臺中人聚餐的首選地段，從火鍋、燒肉到中式料理與早午餐，每走幾步就有驚喜。以下是我實際造訪過的10間代表性餐廳清單，橫跨平價、創意、高級各路風格。 餐廳名稱 料理類型 價位範圍（每人） 推薦菜色 適合族群 我的評價摘要 1️⃣ 一頭牛日式燒肉 和牛燒肉 $1200~$1400 A5和牛拼盤、 旬味野炊飯 情侶慶祝、燒肉愛好者 肉質頂級、陶瓷烤爐，沒有用木炭 2️⃣ TANG Zhan 湯棧 火鍋 / 麻香鍋 $500–$800 麻香鍋、麻油雞鍋 情侶、朋友、文青聚會 文青風火鍋代表，湯底濃郁卻不膩、環境質感佳 3️⃣ NINI 尼尼臺中店 義式料理 / 早午餐 $400–$700 松露燉飯、薄餅披薩 姊妹聚會、家庭聚餐 採光好、氣氛輕鬆，餐點份量實在 4️⃣ 加分100%浜中特選昆布鍋物 北海道鍋物 $400–$700 牛奶昆布鍋、海鮮拼盤 家庭聚餐、親子用餐 湯底細緻清爽、CP值高、服務親切 5️⃣ 印月餐廳 中式創意料理 / 宴會餐廳 $800–$1500 松露雞湯、蒜香牛肋條 商務宴客、家庭聚餐 菜色融合創意與傳統，氣氛高雅 6️⃣ KoDō 和牛燒肉 高檔日式燒肉 $1200–$2000 冷藏肋眼、壽喜燒套餐 節慶慶祝、燒肉控 儀式感十足、肉質極佳、服務細膩 7️⃣ 永心鳳茶 臺式茶館 / 早午餐 $300–$500 炸雞腿飯、鳳茶甜點 姊妹下午茶、親子餐聚 茶香融入料理，氛圍優雅放鬆 8️⃣ 三希樓 江浙菜 / 港點 $600–$900 小籠包、東坡肉 家庭聚餐、長輩慶生 火候精準、味道穩定，傳統中菜代表 9️⃣ 一笈壽司 日式壽司 / 無菜單料理 $1000–$1500 握壽司套餐、生魚片 日料控、紀念日用餐 食材新鮮、主廚手藝細膩，私密高雅 🔟 茶六燒肉堂 和牛燒肉 / 精緻套餐 $700–$1000 厚切牛舌、和牛拼盤 家庭、情侶、朋友聚餐 品質穩定、氣氛熱絡，年輕族群最愛 一頭牛日式燒肉｜炭香濃郁的和牛饗宴，約會聚餐首選   走在公益路上，很難不被 一頭牛日式燒肉 的木質外觀吸引。低調卻不失質感的門面，搭配昏黃燈光與暖色調的內裝，讓人一進門就感受到濃濃的日式職人氛圍。店內空間不大，但桌距規劃得宜，每桌皆設有獨立排煙設備，烤肉時完全不怕滿身油煙味。 餐點特色 一頭牛的靈魂，絕對是他們招牌的「三國和牛拼盤」。 嚴選的和牛部位，共八個部位、十樣餐點，讓人能從牛頭一路品嘗到牛尾。 油花分布均勻、切片厚薄恰好，經過炭火烤炙後香氣四溢，焦香與油脂在口中交融，入口即化的滑順感令人難忘。 值得一提的是，一頭牛的菜單設計十分彈性 想要一次體驗完整套餐也可以，偏好客製口味則能自由單點組合，不受套餐限制，想吃什麼就點什麼。 而且每桌都能選擇「自行燒烤」或「專人代烤」服務，烤肉管家的火侯掌握與節奏讓整體體驗更輕鬆愉快。 除了主角和牛，旬味野炊飯 與 主廚冰淇淋 也是隱藏版亮點，前者粒粒分明、香氣撲鼻；後者以香草與焙茶為基底，隨季節更換口味，完美收尾。整體服務親切熱情，特別是壽星還能享有 生日畫盤驚喜，讓慶祝時刻更添儀式感。 用餐體驗 整體節奏掌握得非常好。店員會在你剛想烤下一片肉時貼心遞上夾子、幫忙換烤網，讓人完全不用分心。整場用餐過程就像一場表演，從視覺、嗅覺到味覺都被滿足。 如果是第一次約會或慶祝特別節日，這裡的氛圍既不尷尬又不吵鬧，是營造氣氛的理想選擇。 綜合評分 評分項目 分數（滿分5分） 評語 環境氛圍 ⭐⭐⭐⭐⭐ 光線柔和、氣氛沉穩，極具日式質感 口味表現 ⭐⭐⭐⭐⭐ A5和牛入口即化、炭香迷人 CP值 ⭐⭐⭐⭐ 價格略高但品質與服務對得起價位 再訪意願 ⭐⭐⭐⭐⭐ 適合慶祝、約會，一吃就難忘的燒肉店 地址：408臺中市南屯區公益路二段162號 電話：04-23206800 官網：https://lihi2.me/Amijw 小結語 一頭牛日式燒肉不僅是「吃肉的地方」，更像是一場五感盛宴。從進門那一刻到最後一道甜點，都能感受到他們對細節的用心。 若要在公益路找一間能讓人「邊吃邊微笑」的燒肉店，一頭牛 絕對值得列入你的必訪清單。 TANG Zhan 湯棧｜文青系火鍋代表，麻香湯底與視覺美感並重 在公益路這條美食戰線上，TANG Zhan 湯棧 是讓人一眼就會想走進去的那一種。 黑灰調的現代外觀、搭配微霧玻璃與招牌的「湯棧」燈字，呈現出一種低調的時尚感。 店內設計延續品牌主題，以「湯」為靈魂打造整體體驗，從裝潢到香氣，都有濃厚的溫潤氣息。 餐點特色 湯棧最有名的當然是它的「麻香鍋」。 湯底以雞骨與多種辛香料慢熬，香氣濃郁卻不嗆辣，入口後會在喉間留下柔和的花椒香。 「招牌麻油雞鍋」與「黃金牛奶鍋」也是人氣選項，特別是在冬天，溫潤的湯底配上滑嫩肉片，讓人每一口都覺得暖心。 他們的「滷肉飯」和「香蔥豆腐皮」更是許多老客人必點的靈魂配角，簡單卻有記憶點。 用餐體驗 整體氛圍比一般火鍋店更有質感。 桌距寬敞、燈光柔和，店員動作俐落又親切。即使客滿，也不會感覺吵雜或壓迫。 不論是一個人想靜靜吃鍋、或是朋友聚餐，湯棧都能給你剛剛好的距離與溫度。 值得一提的是，上菜速度快、湯底續湯毫不手軟，細節服務到位。 綜合評分 評分項目 分數（滿分5分） 評語 環境氛圍 ⭐⭐⭐⭐⭐ 文青感強、光線柔和，是拍照好選擇 口味表現 ⭐⭐⭐⭐☆ 麻香濃郁、湯頭層次豐富、不油不膩 CP值 ⭐⭐⭐⭐ 份量足、價格中等偏上 再訪意願 ⭐⭐⭐⭐⭐ 冬天或雨天時會特別想再訪的火鍋店 地址：408臺中市南屯區公益路二段248號 電話：04-22580617 官網：https://www.facebook.com/TangZhan.tw/ 小結語 TANG Zhan 湯棧 把傳統火鍋做出新的樣貌  保留臺式鍋物的溫度，又結合現代風格與細節服務，讓吃鍋這件事變得更有品味。  如果你想找一間兼具「好吃、好拍、好放鬆」的火鍋店，湯棧會是公益路上最有風格的選擇之一。 NINI 尼尼臺中店｜明亮寬敞的義式早午餐天堂 如果說前兩間是肉食愛好者的天堂，那 NINI 尼尼臺中店 絕對是想放鬆、聊聊天的好地方。餐廳外觀以白色系與大片玻璃窗為主，陽光灑進室內，讓人一踏入就有種度假般的輕盈感。假日早午餐時段特別熱鬧，建議提早訂位。 餐點特色 NINI 的菜單融合義式與臺灣人口味，選擇多樣且份量十足。主打的 松露燉飯 濃郁卻不膩口，米芯保留微Q口感；而 香蒜海鮮義大利麵 則以新鮮白蝦、花枝與淡菜搭配微辣蒜香，口感層次豐富。 此外，他們的薄餅披薩相當受歡迎，餅皮薄脆、餡料新鮮，是三五好友共享的好選擇。 用餐體驗 店內氣氛輕鬆不拘謹，無論是一個人帶電腦工作、或朋友聚餐，都能找到舒服角落。餐點上桌速度穩定，服務人員態度親切、補水與收盤都非常主動。整體節奏讓人覺得「時間變慢了」，很適合想遠離忙碌日常的人。 綜合評分 評分項目 分數（滿分5分） 評語 環境氛圍 ⭐⭐⭐⭐⭐ 採光好、座位寬敞，氛圍悠閒舒適 口味表現 ⭐⭐⭐⭐ 義式風味穩定，燉飯與披薩表現亮眼 CP值 ⭐⭐⭐⭐ 價位合理、份量實在 再訪意願 ⭐⭐⭐⭐ 適合假日早午餐或輕鬆聚會再訪 地址：40861臺中市南屯區公益路二段18號 電話：04-23288498 官網：https://nini.com.tw/ 小結語 NINI 尼尼臺中店是一間能讓人放下手機、慢慢吃飯的餐廳。餐點不追求浮誇，而是以「剛剛好」的份量與風味，陪伴每個平凡午後。  如果你在找一間能邊吃邊聊天、拍照也漂亮的早午餐店，NINI 會是你在公益路上最不費力的幸福選擇。 加分100%浜中特選昆布鍋物｜平價卻用心的湯頭系火鍋，家庭聚餐好選擇 在公益路這條高質感餐廳林立的戰場上，加分100%浜中特選昆布鍋物 走的是截然不同的路線。它沒有浮誇的裝潢、也沒有高價位的套餐，但靠著實在的湯頭與親切的服務，默默吸引許多回頭客。每到用餐時間，總能看到家庭或情侶三兩成群地圍著鍋邊聊天。 餐點特色 主打 北海道浜中昆布湯底，湯頭清澈卻不單薄，越煮越能喝出海藻與柴魚的自然香氣。 我這次點的是「牛奶昆布鍋」，入口時奶香與昆布香完美融合，搭配新鮮的牛五花肉片，滑順又不膩。 菜盤走健康取向，蔬菜比例高，連玉米、南瓜、豆皮都能吃出甜味；附餐的烏龍麵Q彈有嚼勁，吃完十分有飽足感。 用餐體驗 整體氛圍偏家庭取向，桌距寬敞、座位舒適，帶小孩來也不覺擁擠。店員態度親切，補湯、收盤都很勤快，給人一種「被照顧著」的安心感。 最難得的是，即使價位不高，食材新鮮度仍維持得很好，能感受到店家對品質的堅持。 綜合評分 評分項目 分數（滿分5分） 評語 環境氛圍 ⭐⭐⭐⭐ 簡約乾淨、座位舒適，適合家庭聚餐 口味表現 ⭐⭐⭐⭐☆ 湯頭清爽細緻、奶香與昆布香交融自然 CP值 ⭐⭐⭐⭐⭐ 份量足、價位親民，整體表現超值 再訪意願 ⭐⭐⭐⭐☆ 想吃鍋又不想花太多時的首選 地址：403臺中市西區公益路288號 電話：0910855180 官網：https://giafine100.com/ 小結語 加分100%浜中特選昆布鍋物是一間「不浮誇、但會讓人想再訪」的火鍋店。它不追求豪華擺盤，而是用最簡單的湯頭與新鮮食材，傳遞出家常卻不平凡的溫度。 如果你想在公益路找一間可以放心帶家人一起吃的鍋物店，這裡絕對會讓人感到「加分」不少。 印月餐廳｜中式料理的藝術演繹，宴客與家庭聚會首選 說到臺中公益路的中式料理代表，印月餐廳 絕對是榜上有名。這間開業多年的餐廳以「中菜西吃」的概念聞名，把傳統中式料理以現代手法重新詮釋。從建築外觀到餐具擺設，每個細節都散發著低調的典雅氣息。 走進印月，挑高的空間、柔和的燈光與木質桌椅構成沉穩的氛圍。 不論是家庭聚餐、商務宴客，還是節日慶祝，都能找到恰到好處的格調。 餐點特色 印月最令人印象深刻的是他們將傳統中菜融入創意手法。 這次我品嚐的「松露雞湯」香氣濃郁、層次分明，一口下去既有中式的溫潤感，又帶出西式松露的奢華香氣。 「蒜香牛肋條」則是另一道招牌菜，外酥內嫩、油香十足，咬下去肉汁在口中散開，搭配特調醬汁非常過癮。 此外，他們的創意港點如「麻辣小籠包」與「金沙流沙包」也深受年輕客群喜愛，既保留經典又玩出新意。 用餐體驗 服務方面完全對得起餐廳的高級定位。從入座、點餐到上菜節奏，都拿捏得恰如其分。每道菜都會有服務人員細心介紹食材與吃法，讓人感受到「被款待」的尊榮感。 雖然價位偏中高，但在這樣的氛圍與品質下，物有所值。 綜合評分 評分項目 分數（滿分5分） 評語 環境氛圍 ⭐⭐⭐⭐⭐ 典雅寬敞、氣氛沈穩，宴客首選 口味表現 ⭐⭐⭐⭐⭐ 每道菜都有層次與記憶點，融合創意與傳統 CP值 ⭐⭐⭐⭐ 價位偏高但品質穩定 再訪意願 ⭐⭐⭐⭐☆ 節慶或招待長輩時會再次選擇 地址：408臺中市南屯區公益路二段818號 電話：0422511155 官網：https://wein818.com/ 小結語 印月餐廳是一間「不只吃飯，更像品味生活」的地方。 它成功地讓中式料理不再只是圓桌菜，而是能展現質感、講究細節的美食體驗。 若你在找一間能同時滿足味蕾與體面的餐廳，印月 絕對是公益路上的不敗經典。 KoDō 和牛燒肉｜極致職人精神，專為儀式感與頂級味覺而生 若要形容 KoDō 和牛燒肉 的用餐體驗，一句話足以總結——「像在欣賞一場關於肉的表演」。 隱身在公益路一隅，KoDō 的外觀低調典雅，店內以深色木質調與間接照明營造出沉穩氛圍。 從踏入店門那一刻開始，服務人員的態度、動線、聲音控制，全都精準到位，讓人彷彿走進日式劇場。 餐點特色 這裡主打 日本A5和牛冷藏肉，以「精切厚燒」的方式呈現。 我點的「壽喜燒風和牛套餐」是本日最驚艷的一道——服務人員現場以鐵鍋輕煎，再淋上特製壽喜燒醬汁，香氣瞬間瀰漫整桌。 肉片油花細緻、入口即化，搭配生蛋液後更添柔滑口感。 另一道「冷藏肋眼心」則保留了和牛的彈性與甜度，每一口都能感受到油脂與炭火交織出的層次。 即使是配角如「季節小菜」與「日式和風飯」也毫不馬虎，整體呈現出高級卻不造作的平衡。 用餐體驗 KoDō 的最大特色是「儀式感」。 每位店員的動作都有節奏，從擺盤、火候、換網到講解，都像排練過無數次的演出。 在這裡用餐，會自然地放慢速度，專注於每一口肉帶來的細膩變化。 特別推薦搭配店內的紅酒或日本威士忌，風味更加圓潤。 綜合評分 評分項目 分數（滿分5分） 評語 環境氛圍 ⭐⭐⭐⭐⭐ 私密高雅、光線柔和，極具儀式感 口味表現 ⭐⭐⭐⭐⭐ 和牛品質極高、火候掌控完美 CP值 ⭐⭐⭐☆ 價位高，但每一口都吃得出誠意 再訪意願 ⭐⭐⭐⭐☆ 節慶、紀念日值得再次造訪 地址：403臺中市西區公益路260號 電話：0423220312 官網：https://www.facebook.com/kodo2018/ 小結語 KoDō 和牛燒肉不是日常餐廳，而是一場體驗。 從環境、服務到食材，每個細節都讓人感受到對「完美」的執著。 若你想在公益路找一間能讓人留下深刻印象、適合紀念日慶祝的餐廳，KoDō 絕對是值得收藏的一次「味覺儀式」。 永心鳳茶｜在茶香裡用餐的優雅時光，臺味早午餐的新詮釋 走進 永心鳳茶公益店，彷彿進入一間有氣質的茶館。 柔和的燈光灑在復古綠牆上，搭配大理石桌面與金色餐具，整體氛圍既典雅又帶有一絲文青氣息。 這裡不只是喝茶的地方，更像是把「臺灣味」以早午餐的形式重新演繹。 餐點特色 永心鳳茶的餐點結合中式靈魂與西式擺盤，無論是「炸雞腿飯」還是「紅玉紅茶拿鐵」，都能讓人感受到熟悉卻不平凡的味道。 炸雞腿外酥內嫩，搭配自製酸菜與溏心蛋，鹹香中帶著層次感。 「鳳茶甜點拼盤」則以茶為靈魂——伯爵茶蛋糕、烏龍茶奶酪、紅茶雪酥，每一口都有細緻的香氣變化。 最特別的是他們的茶飲，從臺灣高山紅茶到金萱冷泡茶，每一壺都現泡現倒，香氣清雅。 對我而言，這不只是一頓飯，更是一段放鬆的午後儀式。 用餐體驗 店內服務人員態度溫和，對茶品介紹詳盡。上餐節奏剛好，不急不徐。 整體氛圍很「耐坐」，許多客人吃完正餐後仍會續點一壺茶聊天。 音樂輕柔、光線柔和，是那種可以靜靜待上兩小時的地方。 綜合評分 評分項目 分數（滿分5分） 評語 環境氛圍 ⭐⭐⭐⭐⭐ 優雅放鬆、裝潢細緻，是拍照與休憩首選 口味表現 ⭐⭐⭐⭐⭐ 茶香融入料理，整體風味溫潤平衡 CP值 ⭐⭐⭐⭐ 餐點份量適中、價位合理 再訪意願 ⭐⭐⭐⭐⭐ 想放鬆、聊天、喝好茶時會立刻想到這裡 地址：40360臺中市西區公益路68號三樓(勤美誠品) 電話：0423221118 官網：https://linktr.ee/yonshin 小結語 永心鳳茶讓人重新定義「臺味」。 它不走傳統路線，而是把熟悉的元素以更細緻、更現代的方式呈現。 無論是姊妹下午茶、親子餐聚，或是想一個人沉澱片刻，永心鳳茶 都是一處能讓人慢下來、品味生活的好地方。 三希樓｜老饕級江浙功夫菜，穩重又帶人情味的中式饗宴 位於公益路上的 三希樓 是許多臺中老饕的口袋名單。 它沒有浮誇的裝潢，卻有一種低調的自信。從大門進入，就能聞到淡淡的醬香與蒸氣味，那是正宗江浙菜的靈魂。 整體裝潢以深木色為主，搭配圓桌與包廂設計，非常適合家庭聚餐或請客宴會。 餐點特色 三希樓的菜色以 江浙與港式料理 為主，兼顧傳統與現代風味。 我這次點了「東坡肉」與「蝦仁炒飯」，兩道都展現了主廚深厚的火候功力。 東坡肉油亮卻不膩，入口即化、鹹甜交織；蝦仁炒飯粒粒分明、香氣十足，每一口都吃得到鑊氣。 此外，「小籠包」皮薄多汁，是幾乎每桌必點的招牌；港點類如「金牌流沙包」與「干貝燒賣」也都表現穩定。 用餐體驗 三希樓的服務給人一種老派但貼心的感覺。 店員上菜節奏掌握得很好，會主動幫忙分菜、收盤，態度沉穩而不打擾。 最讓我印象深刻的是，這裡的客群非常多元——有帶長輩的家庭、公司聚餐，也有情侶共度節日，卻都能在同一空間裡感到自在。 綜合評分 評分項目 分數（滿分5分） 評語 環境氛圍 ⭐⭐⭐⭐ 傳統圓桌設計、氛圍穩重舒適 口味表現 ⭐⭐⭐⭐⭐ 火候精準、味道濃郁，經典不失真 CP值 ⭐⭐⭐⭐ 價格合理、份量足，適合多人共享 再訪意願 ⭐⭐⭐⭐ 家庭聚餐與宴客的安心首選 地址：408臺中市南屯區公益路二段95號 電話：0423202322 官網：https://www.sanxilou.com.tw/ 小結語 三希樓是一間「吃得出功夫」的餐廳。 它不追求創新，而是用穩定的味道與真材實料，抓住每一位饕客的胃。 如果你想在公益路上找一間能兼顧長輩口味、氣氛又不拘謹的中餐廳，三希樓 絕對是最穩妥的選擇。 一笈壽司｜低調奢華的無菜單日料，職人手藝詮釋旬味極致 在熱鬧的公益路上，一笈壽司 低調得幾乎不顯眼。 外觀簡約，沒有華麗招牌，只有小小的木質門面與柔黃燈光。 一推開門，迎面而來的是日式杉木香氣與寧靜的氛圍，吧檯座位整齊排列，主廚站在中間，彷彿舞臺上的演出者。 餐點特色 一笈壽司採 Omakase（無菜單料理） 形式，每一餐都由主廚根據當日食材設計。 我這次選擇中價位套餐（約 $1200），共十多道料理，從前菜、小鉢、刺身、握壽司到甜點一氣呵成。 「比目魚鰭邊握」是整場最驚豔的瞬間——主廚以火槍輕炙，油脂瞬間釋放，入口後化成柔滑香氣。 「甜蝦海膽軍艦」則完美展現鮮度與層次感，海膽甘甜、甜蝦緊實。 搭配主廚親自調配的醬汁，每一口都像在品嚐季節的節奏。 用餐體驗 整場用餐約90分鐘，節奏緩慢但沉穩。 主廚會邊料理邊與客人互動，介紹魚種產地與食材處理方式。 雖然整體空間不大，但氣氛極佳——柔和的音樂、清酒的香氣、刀刃切魚時的聲音，讓人完全沉浸其中。 特別喜歡他們最後的甜點「焙茶奶酪」，收尾清爽優雅，為整場體驗畫下完美句點。 綜合評分 評分項目 分數（滿分5分） 評語 環境氛圍 ⭐⭐⭐⭐⭐ 私密安靜、燈光柔和，儀式感十足 口味表現 ⭐⭐⭐⭐⭐ 食材新鮮、刀工精準、層次分明 CP值 ⭐⭐⭐⭐ 以品質與體驗來說，價位合理 再訪意願 ⭐⭐⭐⭐⭐ 適合紀念日或想犒賞自己時再訪 地址：408臺中市南屯區公益路二段25號 電話：0423206368 官網：https://www.facebook.com/YIJI.sushi/ 小結語 一笈壽司是一間真正讓人「放慢呼吸」的餐廳。 這裡沒有多餘擺盤，也不靠噱頭，而是以主廚對食材的尊重與技術堆疊出一場味覺饗宴。 若你想在公益路體驗日本料理最純粹的精神，一笈壽司 絕對值得你預約、靜靜期待。 茶六燒肉堂｜人氣爆棚的和牛燒肉聖地，肉香與幸福感同時滿分 若要票選公益路上「最難訂位」的餐廳，茶六燒肉堂 絕對名列前茅。 不管平日或假日，用餐時段幾乎一位難求。外觀以木質格柵搭配大面玻璃設計，呈現出年輕又有質感的風格。店內空間明亮、桌距適中，播放著輕快的音樂，整體氛圍熱鬧中帶點高級感，是許多年輕人聚餐、慶生的首選地。 餐點特色 茶六主打 和牛燒肉套餐，價格約落在 $700–$1000 間，份量與品質兼具。 我這次點的是「厚切牛舌套餐」，肉片厚實彈牙，略帶脆感，搭配鹽蔥提味剛剛好。 另一道「和牛拼盤」也相當受歡迎，油花分布均勻、香氣濃郁，輕烤幾秒即可入口即化。 套餐附餐部分也相當用心：沙拉新鮮、味噌湯濃郁，最後還有一份「茶香冰淇淋」作結尾，香氣清爽，完美收尾。 用餐體驗 茶六的服務效率相當高。店員親切、換網勤快、補水速度快，整場用餐流程流暢無壓力。 雖然客人很多，但環境維持得乾淨整潔，動線規劃良好。 最令人印象深刻的是他們的 整體節奏拿捏得剛剛好 ——餐點上桌快、氣氛熱絡，卻不會讓人覺得匆忙。 不論是朋友聚會、家庭聚餐，甚至是情侶約會，都能找到各自的樂趣。 綜合評分 評分項目 分數（滿分5分） 評語 環境氛圍 ⭐⭐⭐⭐ 明亮活潑、氣氛熱絡但不嘈雜 口味表現 ⭐⭐⭐⭐⭐ 肉質穩定、調味自然、甜點有記憶點 CP值 ⭐⭐⭐⭐⭐ 價格實在、份量足，是高回訪率代表 再訪意願 ⭐⭐⭐⭐⭐ 聚會、慶生都會再次選擇的燒肉店 地址：403臺中市西區公益路268號 電話：0423281167 官網：https://inline.app/booking/-L93VSXuz8o86ahWDRg0:inline-live-karuizawa/-LUYUEIOYwa7GCUpAFWA 小結語 茶六燒肉堂用「穩定品質＋輕奢氛圍」抓住了臺中年輕族群的心。 不論是第一次約會還是老朋友重聚，都能在這裡找到屬於燒肉的快樂節奏。 若你在公益路只想挑一家「保證不踩雷」的燒肉店，茶六燒肉堂 絕對是首選。 吃完10家公益路餐廳後的心得與結語 吃完這十家餐廳後，臺中公益路不只是一條美食街，而是一段生活風景線。 有的餐廳講究細膩與儀式感，像 一頭牛日式燒肉 與 一笈壽司，讓人感受到食材最純粹的美好 有的則以親切與溫度打動人心，像 加分昆布鍋物、永心鳳茶，讓人明白吃飯不只是為了飽足，而是一種被照顧的幸福。 而像茶六燒肉堂、TANG Zhan 湯棧 這類人氣名店，則用穩定的品質與熱絡的氛圍，成為許多臺中人心中「想吃肉就去那裡」的代名詞。 這十家店，構成了公益路最動人的縮影 有華麗的，也有溫柔的；有傳統的，也有創新的。  每一家都在自己的風格裡發光，讓人吃到的不只是料理，而是一種生活的溫度與節奏。 對我而言，這不僅是一場美食旅程，更是一趟關於「臺中味道」的回憶之旅。 FAQ：關於臺中公益路美食常見問題 Q1：公益路哪一區的餐廳最集中？  最熱鬧的區段大約在「公益路與黎明路口」一帶，這裡聚集了許多知名餐廳，從高級燒肉到早午餐通通有。 像 一頭牛日式燒肉、TANG Zhan 湯棧、茶六燒肉堂 都在這附近，交通方便、停車也相對容易。 Q2：需要提前訂位嗎？  公益路的熱門餐廳幾乎都建議 提早3～5天訂位，尤其是假日或節慶期間。 特別是 一頭牛日式燒肉、KoDō 和牛燒肉、一笈壽司 這幾家，若臨時前往幾乎很難有位。 最後的話 若要用一句話形容這趟美食之旅，我會說： 「在公益路，吃飯不是選擇，而是一種享受。」 這條路上的每一次用餐，都像一段城市裡的小旅行。 下次當你不確定想吃什麼時，不妨沿著公益路走一圈，或許下一家，正好就是你新的最愛。 一笈壽司適合聚餐嗎？ 如果你也和我一樣喜歡用味蕾探索一座城市，那就把這篇公益路美食攻略收藏起來吧。加分100%浜中特選昆布鍋物家庭過節聚會適合嗎？ 無論是約會、慶生、家庭聚餐，或只是想犒賞一下辛苦的自己——這條路上永遠會有一間剛剛好的餐廳在等你。永心鳳茶氣氛如何？ 下一餐，不妨從這10家開始。TANG Zhan 湯棧價格合理嗎？ 打開手機、約上朋友，讓公益路成為你生活裡最容易抵達的小確幸。永心鳳茶平日好排隊嗎？ 如果你有私心愛店，也歡迎留言分享，茶六燒肉堂長輩會喜歡嗎？ 你的推薦，可能讓我下一趟美食旅程變得更精彩。永心鳳茶節慶時段會不會太難訂位？ Neurons (green) containing tau aggregates (red). Credit: S. Sanford – UK DRI at the University of Cambridge Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader application in neurodegenerative diseases. Researchers have developed promising new therapies that selectively target and destroy aggregated tau proteins, which are associated with Alzheimer’s disease, and improve symptoms of neurodegeneration in mice. According to the researchers, this approach could also be applied in the future to other brain disorders driven by protein aggregation inside cells, such as motor neuron disease, Parkinson’s disease, and Huntington’s disease. This groundbreaking research, conducted by the Medical Research Council Laboratory of Molecular Biology (MRC LMB) in Cambridge, UK, and the UK Dementia Research Institute (UK DRI) at the University of Cambridge, was detailed in two new papers, published in Cell and Science. Cells containing tau aggregates (green) before (left) and 13 hours after treatment with RING-nanobody (right). Credit: J. Benn – UK DRI at the University of Cambridge Advantages of TRIM21-Based Therapies In the new studies, the team demonstrated how utilizing the unique capabilities of a protein called TRIM21 gives the potential therapies two key advantages. Firstly, they only destroyed the disease-linked tau aggregates, leaving healthy tau proteins intact. Secondly, the therapies removed already established tau aggregates in mice, not just preventing the formation of new aggregates. How RING-bait tags aggregated tau for destruction. Credit: L. Miller and G. Papa, MRC Laboratory of Molecular Biology Challenges in Targeting Tau Two main proteins become misfolded and accumulate into aggregates in the brains of people affected by Alzheimer’s disease: tau and amyloid. Amyloid aggregates form in the spaces between brain cells, where they are being targeted by new antibody therapies, such as lecanemab. In contrast, tau ‘tangles’ largely form inside nerve cells, although aggregates can spread from cell to cell, which is strongly associated with cognitive decline as the disease progresses. It is difficult for antibody therapies to access tau inside cells, therefore they do not remove existing tau aggregates inside cells – at best they prevent aggregates from spreading. Other techniques for targeting tau inside cells, such as anti-sense oligonucleotides (ASOs), have been shown to reduce tau in promising early-stage clinical trials. However, they act on all tau in the brain and therefore also remove ‘healthy’ tau – the long-term side-effects of this are not yet known. ‘Healthy’ tau protein normally helps to provide structural support inside nerve cells in the brain – acting as a type of scaffolding. The aggregated tau (green dots) is hugely reduced in cells treated with the RING-nanobody over 20 hours. Credit: Jonathan Benn – UK DRI at the University of Cambridge Innovative Approach Using TRIM21 This new technique for targeting tau tangles utilizes a 2010 discovery from Dr. Leo James’ lab at the MRC Laboratory of Molecular Biology of the role of a unique protein called TRIM21, which is a key part of the immune response to viruses. Outside the cell, the body produces antibodies that bind to invading viruses. When the antibody-bound virus enters a cell, TRIM21 detects it and tags the virus as ‘garbage’, handing it over to the cell’s ‘garbage chute’, the proteasome, for destruction. The same team, working across the UK DRI and MRC LMB, demonstrated in 2023 that TRIM21 could be re-purposed to destroy tau protein aggregates associated with Alzheimer’s disease. By switching out antibodies that bind viruses for antibodies that bind to tau, TRIM21 was re-directed to send tau aggregates to be destroyed by the proteasome. TRIM21 is particularly suited to this because of a special feature – a part of the protein called ‘RING’ that is activated only when two or more TRIM21 proteins cluster together. This means that it only activates and marks its target for destruction when TRIM21 proteins are bound to adjacent, aggregated tau proteins. The gait of mice with tauopathy improved after treatment with RING-Bait (top, orange). Mice given the placebo retained poor gait (bottom, purple). Credit: MRC Laboratory of Molecular Biology Development of New Tau Aggregate Therapies In the new studies, scientists have used TRIM21 to create two new therapies to target tau aggregates. The first therapy, ‘RING-nanobody’, combines a tau-binding nanobody – a miniature version of an antibody – with the TRIM21 RING. The second therapeutic, ‘RING-Bait’, has the TRIM21 RING joined to a copy of the tau protein itself. The RING-linked tau protein acts as bait – the aggregates incorporate it and TRIM21 RING gets incorporated as well. Once multiple RING-Baits are added to the aggregate, they become activated and cause the entire aggregate to be destroyed. The researchers delivered the DNA encoding the TRIM21 therapies into cells containing aggregated tau and found it cleared the tau tangles. As hoped, ‘healthy’ tau was left undamaged. RING-Bait (green) reduces tau aggregates (red) in a mouse brain. Credit: L. Miller, MRC Laboratory of Molecular Biology Dr. Will McEwan, co-leader of the studies, from the UK Dementia Research Institute at the University of Cambridge, said: “Tau aggregates are tucked away inside brain cells and very difficult to degrade. Critically, these new TRIM21-based therapies can be delivered directly inside cells, where the majority of tau aggregates reside. “We’ve found a way that not only degrades the tau aggregates, but leaves the healthy tau intact to do its job. The new strategy goes beyond what can be achieved with current ASO therapies that are being trialed, as it could avoid any potential long-term side-effects of eliminating normal tau.” Aggregated tau (red) remains in a mouse brain treated with the placebo (green). Credit: L. Miller, MRC Laboratory of Molecular Biology Since different neurodegenerative diseases can have different types of misfolded tau, they tested the therapies on cells containing aggregated tau proteins from brain tissue donated by people who had Alzheimer’s disease or progressive supranuclear palsy, which have different misfolded tau structures. The RING-Bait therapy was able to prevent tau aggregation induced by proteins from both Alzheimer’s and progressive supranuclear palsy patient brains. Dr. Leo James, co-leader of the studies, from the MRC Laboratory of Molecular Biology in Cambridge, said: “Neurodegenerative diseases can have tau proteins that misfold in many different ways, raising the possibility of needing a different treatment for every disease. A useful aspect of RING-Bait is because it is attached to a tau protein, it’s a universal Trojan horse that should be incorporated into different types of tau aggregates exactly like the cell’s own misfolding tau protein.” Promising Results in Mice Models For the treatment to work in an animal, it needs to not only get into the brain but also get inside the cells within the brain. To do this, the researchers used a harmless virus that has previously been developed to deliver therapies like this, called an adeno-associated virus (AAV). It delivers DNA instructions to make the custom proteins inside brain cells. Elderly mice with tau protein aggregates were injected with a single dose of the gene therapy vector containing either the treatment or a placebo. Within a few weeks, there was a significant reduction in the amount of aggregated tau in the brain cells of the treated animals. Importantly, in the mice given the RING-Bait treatment, the progression of their neurodegeneration symptoms slowed and they showed significantly better motor function, as assessed by an AI program that scored how well they ran. “It was unknown whether specifically removing tau aggregates inside the cell would be enough to halt the progression of disease. It is encouraging that a RING-Bait approach reduces disease severity in our model systems, as this suggests that the selective removal of tau aggregates is a valid therapeutic approach. Further work will be needed to demonstrate this beneficial effect is found across multiple models of human disease,” said Dr. Lauren Miller, a study author, who worked across both the UK Dementia Research Institute and MRC Laboratory of Molecular Biology. Implications for Future Neurodegenerative Disease Therapies Dr. Guido Papa, a study author, from the MRC Laboratory of Molecular Biology, said: “The beauty of RING-Bait lies in its broad adaptability and the potential to tackle other conditions characterized by the accumulation of pathological protein clusters. Other neurodegenerative diseases are caused by aggregates formed by other proteins, such as TDP43 in motor neuron disease and alpha-synuclein in Parkinson’s disease. It is hoped that RING-Bait will allow the development of future therapies that directly target the aggregation process in these diseases.” Toward Human Trials The scientists caution that these therapies still require a lot of development before they can be tested in humans, particularly developing an AAV vector that can safely and effectively deliver RING-nanobody or RING-bait therapies to cells throughout the human brain. Dr. Jonathan Benn, a study author, from the UK Dementia Research Institute at the University of Cambridge, said: “It’s important to stress that although we have shown it works in a mouse model, this is a long way from a therapeutic that could be used in humans. It would need to be determined that it is safe to use TRIM21-based therapies in the human brain and that the treatments are effective in both removing aggregates and improving the course of disease. “Some AAV vectors are already approved for use in humans – for instance in degenerative eye diseases and genetic diseases like spinal muscular atrophy. However, getting enough AAV into the adult brain remains a significant challenge – the human brain is about 1,000 times bigger than a mouse brain. But this is a rapidly moving field and there are cutting-edge gene delivery methods that we hope will allow our therapies to be delivered at scale in the future.” References: “Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function” by Lauren V.C. Miller, Guido Papa, Marina Vaysburd, Shi Cheng, Paul W. Sweeney, Annabel Smith, Catarina Franco, Taxiarchis Katsinelos, Melissa Huang, Sophie A.I. Sanford, Jonathan Benn, Jasmine Farnsworth, Katie Higginson, Holly Joyner, William A. McEwan and Leo C. James, 13 September 2024, Cell. DOI: 10.1016/j.cell.2024.08.024 “Aggregate-selective removal of pathological tau by clustering-activated degraders” by Jonathan Benn, Shi Cheng, Sophie Keeling, Annabel E. Smith, Marina J. Vaysburd, Dorothea Böken, Lauren V. C. Miller, Taxiarchis Katsinelos, Catarina Franco, Elian Dupré, Clément Danis, Isabelle Landrieu, Luc Buée, David Klenerman, Leo C. James and William A. McEwan, 29 August 2024, Science. DOI: 10.1126/science.adp5186 These studies were primarily funded by Wellcome, MRC, UK DRI, and The Lister Institute of Preventative Medicine. Mouse embryos, like the one depicted here, die in utero if they are missing the choline transporter FLVCR1. But giving them supplemental choline can increase their lifespan. Credit: Laboratory of Metabolic Regulation and Genetics at The Rockefeller University Scientists identified FLVCR1 as the choline transporter protein, offering a direct therapeutic pathway for PCARP. Proteins integrated into the cell membrane play a crucial role in transporting nutrients to the intended destination within our cells. If this transportation system malfunctions and metabolites are unable to reach their target, it can have adverse effects on human health, ranging from rare illnesses to neurodegenerative disorders and even cancer. A deeper comprehension of how metabolites are transported into cells could pave the way for potential therapies for diseases associated with metabolite transportation. But matching which proteins transport which nutrients has proven difficult—to date, some 30 percent of carrier proteins have yet to be mapped back to their nutrients. Now, a new study reveals the protein responsible for transporting choline into the cell. The findings, published in Cell Metabolism, may have immediate implications for people living with posterior column ataxia with retinitis pigmentosa (PCARP), a disease caused by a mutation in this transporter protein. “You can get supplemental choline over-the-counter—it’s easily administered and patients can tolerate fairly high levels of it,” says Timothy Kenny, a postdoctoral fellow in the laboratory of Kivanc Birsoy at Rockefeller. “Our findings could be easily translated into the clinic.” The results may also pave the way for further discoveries that chip away at the inner workings of other transport proteins and diseases that are linked to their dysfunction. “The whole study is a proof of concept,” Birsoy says. “By systematically identifying so-called ‘orphan’ transport proteins, we can solve mysteries not only in human biology but also in human health.” A Metabolite in a Haystack There are about 5,000 different metabolites in human blood, and scientists still do not know how many of them enter cells. Determined to change that, Birsoy, Kenny, and colleagues began investigating transport proteins. The team took a uniquely broad approach to the problem and scoured scores of studies mapping associations between transporters and metabolites across the entire human genome. Casting a wide net bore fruit, and one metabolite—choline—was shown to be very strongly associated with a membrane transport protein known as FLVCR1. “Within our data, one could actually pull out multiple transport proteins linked to specific metabolites,” Birsoy says. “We chose to focus on choline because it had the strongest signal.” Choline was also an appealing choice because of the bevy of diseases associated with its deficiency. “Choline is a key component of cell membranes and neurotransmitters, so it’s biologically important, and choline deficiency is also associated with fetal alcohol spectrum disorders, neurodegeneration, liver disease, and some cancers,” Birsoy says. The fact that prior studies have noted a link between FLVCR1 mutations and PCARP (which results in vision problems, muscle weakness, and difficulties with spatial orientation) only sharpened the team’s sense that they had hit on a possible pairing with important implications. Confirming Choline Birsoy and colleagues then conducted a series of experiments to definitively demonstrate that FLVCR1 was indeed the transporter in question. They found that mice without FLVCR1 die in utero (but live longer if given supplemental choline), and that human cells missing the gene that produces FLVCR1 are not only choline-deficient, but also can have their metabolism corrected with the equivalent gene in flies—a demonstration of just how fundamental to life the gene must be. Moreover, the experiment with mouse embryos provided evidence that FLVCR1 mutations may be treatable with supplemental choline. If that holds in humans, that would mean that it may make more sense to provide PCARP patients’ missing choline through a dietary supplement than to try to fix the transporter that should have been bringing choline into their cells. “Scientists knew that PCARP was linked to FLVCR1, but they didn’t know that FLVCR1 was linked to choline, so providing supplemental choline for PCARP patients was not even considered,” Kenny says. “This is an example of how basic biology allows us to rationally design therapies.” Meanwhile, the Birsoy lab intends to use the method described in this study to identify more mystery connections between metabolites and transporters. “Given that many transporters are associated with diseases and drug targets, identifying these transporters is a top priority,” Birsoy says. “We have now devised one important strategy for accomplishing this.” Reference: “Integrative genetic analysis identifies FLVCR1 as a plasma-membrane choline transporter in mammals” by Timothy C. Kenny, Artem Khan, Yeeun Son, Lishu Yue, Søren Heissel, Anurag Sharma, H. Amalia Pasolli, Yuyang Liu, Eric R. Gamazon, Hanan Alwaseem, Richard K. Hite and Kıvanç Birsoy, 25 April 2023, Cell Metabolism. DOI: 10.1016/j.cmet.2023.04.003 New research has demonstrated that seaweed, long used as an indicator of coral reef health, may be providing misleading information. The study, which analyzed data from over 1,200 oceanic sites, suggests that different species of macroalgae react differently to contamination, potentially obscuring signs of reef stress and misdirecting conservation efforts. New research shows that seaweed is an unreliable indicator of reef health, as different species respond uniquely to environmental stress, potentially obscuring human impact. Scientists have been using seaweed as an indicator of coral reef health for decades. But what if the seaweed was misleading them? New University of British Columbia research reveals it was, and scientists need new ways to determine whether human activity is harming a particular reef. “This is especially critical today, given that reefs globally are threatened by climate-driven stressors,” said Dr. Sara Cannon, a postdoctoral fellow at the UBC Institute for the Oceans and Fisheries and the study’s lead author. Local Species Behave Differently Seaweed belongs to a group of organisms called macroalgae. Macroalgae at the ocean’s surface has long served as a proxy for reef health, because it is relatively quick and easy to measure. Since the 1970s, scientists have assumed that local human impacts increase macroalgae while simultaneously damaging underlying reefs. However, the study just published in Global Change Biology looked at data from over 1,200 sites in the Indian and Pacific Oceans over a 16-year period and revealed that this approach is misleading and may even have hidden signs of reef stress. For example, macroalgae coverage depends heavily on the species growing in a particular area. Sargassum is less likely to grow in water contaminated by agricultural runoff, but Halimeda will thrive. In both cases, a reef will suffer. The global research team concluded that using macroalgae coverage as an indicator of local human impacts can actually obscure how much our actions are harming reefs, and cause scientists to misidentify the reefs most in need of intervention. Reference: “Macroalgae exhibit diverse responses to human disturbances on coral reefs” by Sara E. Cannon, Simon D. Donner, Angela Liu, Pedro C. González Espinosa, Andrew H. Baird, Julia K. Baum, Andrew G. Bauman, Maria Beger, Cassandra E. Benkwitt, Matthew J. Birt, Yannick Chancerelle, Joshua E. Cinner, Nicole L. Crane, Vianney Denis, Martial Depczynski, Nur Fadli, Douglas Fenner, Christopher J. Fulton, Yimnang Golbuu, Nicholas A. J. Graham, James Guest, Hugo B. Harrison, Jean-Paul A. Hobbs, Andrew S. Hoey, Thomas H. Holmes, Peter Houk, Fraser A. Januchowski-Hartley, Jamaluddin Jompa, Chao-Yang Kuo, Gino Valentino Limmon, Yuting V. Lin, Timothy R. McClanahan, Dominic Muenzel, Michelle J. Paddack, Serge Planes, Morgan S. Pratchett, Ben Radford, James Davis Reimer, Zoe T. Richards, Claire L. Ross, John Rulmal Jr., Brigitte Sommer, Gareth J. Williams and Shaun K. Wilson, 5 April 2023, Global Change Biology. DOI: 10.1111/gcb.16694 RRG455KLJIEVEWWF

最新創作

三希樓婚前派對適合嗎？》台中公益路餐廳推薦｜10間必吃美食實測評比 2026/04/22 00:34:11 ｜瀏覽 11 回應 0 推薦 0 引用 0

一笈壽司適合辦部門小聚嗎？》公益路餐廳推薦Top10｜吃貨親訪真實心得 2026/04/19 20:12:46 ｜瀏覽 18 回應 0 推薦 0 引用 0

FB社群經營推薦服務》KSD蝦皮直播觀看代操平台：穩定成長不被系統懲罰 2026/03/21 04:28:23 ｜瀏覽 18 回應 0 推薦 0 引用 0

永和韓國枕套高CP值團購好選擇》採購四季通用四季被？嵩昊韓國款式一次到位 2026/02/23 20:56:09 ｜瀏覽 22 回應 0 推薦 0 引用 0

新北韓國涼感墊適合夏季開團 》從床包批發到品牌經營，嵩昊與您並肩同行 2026/01/13 03:34:21 ｜瀏覽 26 回應 0 推薦 0 引用 0